Variant report
Variant | esv1812349 |
---|---|
Chromosome Location | chr12:60516593-60524969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75394648 | chr12:60516596-60516597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145851478 | chr12:60516617-60516618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148564063 | chr12:60516628-60516629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555368973 | chr12:60516655-60516656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574878754 | chr12:60516660-60516661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543919642 | chr12:60516668-60516669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577927971 | chr12:60516725-60516726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76859129 | chr12:60516726-60516727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78970066 | chr12:60516730-60516731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1493325 | chr12:60516761-60516762 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs73109750 | chr12:60516797-60516798 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs202109633 | chr12:60516808-60516809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142915813 | chr12:60516824-60516825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190628821 | chr12:60516830-60516831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569288493 | chr12:60516863-60516864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146586364 | chr12:60516888-60516889 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370100632 | chr12:60516945-60516946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75478945 | chr12:60516983-60516984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571726733 | chr12:60517028-60517029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181010715 | chr12:60517103-60517104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12303842 | chr12:60517110-60517111 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs79382245 | chr12:60517112-60517113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185942364 | chr12:60517166-60517167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550607417 | chr12:60517206-60517207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536986714 | chr12:60517245-60517246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141297505 | chr12:60517246-60517247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75411119 | chr12:60517256-60517257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200614110 | chr12:60517300-60517301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557441218 | chr12:60517302-60517303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146790712 | chr12:60517324-60517325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191270739 | chr12:60517330-60517331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75694867 | chr12:60517363-60517364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573718107 | chr12:60517377-60517378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532909569 | chr12:60517384-60517385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7133660 | chr12:60517406-60517407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562722360 | chr12:60517434-60517435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7955044 | chr12:60517481-60517482 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs374415871 | chr12:60517484-60517485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551839202 | chr12:60517515-60517516 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565276609 | chr12:60517552-60517553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140422831 | chr12:60517642-60517643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547556469 | chr12:60517662-60517663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567865055 | chr12:60517748-60517749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536418276 | chr12:60517772-60517773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550064108 | chr12:60517775-60517776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377741190 | chr12:60517786-60517787 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185895182 | chr12:60517789-60517790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557381279 | chr12:60517793-60517794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200567504 | chr12:60517798-60517799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60259520 | chr12:60517830-60517831 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60516200-60518800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr12:60516400-60517800 | Enhancers | NHLF | lung |
3 | chr12:60516400-60518200 | Enhancers | Hela-S3 | cervix |
4 | chr12:60516800-60517800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr12:60516800-60518200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr12:60516800-60518200 | Enhancers | NHDF-Ad | bronchial |
7 | chr12:60517200-60517600 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr12:60517200-60517800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr12:60517200-60517800 | Enhancers | A549 | lung |
10 | chr12:60517600-60517800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr12:60517800-60523600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr12:60518800-60520200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr12:60519000-60519800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
14 | chr12:60519000-60520600 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
15 | chr12:60519400-60520400 | ZNF genes & repeats | iPS-18 Cell Line | embryonic stem cell |
16 | chr12:60519800-60520400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |